Tag Archives: Jadenu

April, 2015

  • 2 April

    FDA Provides Accelerated Approval to Novartis’ Jadenu

    The US Food and Drug Administration (FDA) recently approved a new, simplified formulation of Novartis’ Exjade (deferasirox) for the treatment of chronic iron overload. The company said that the agency approved its Jadenu (deferasirox) tablets for oral suspension for the treatment of chronic iron overload due to blood transfusions in …